Marker Therapeutics, Inc.

Monthly Archives: October 2017

A Personal Letter to the Shareholders from TapImmune’s New Chief Executive Officer

Peter L. Hoang pens a personal letter to TapImmune’s shareholders.

Read More

TapImmune to Present at the 2017 BioFlorida Conference

TapImmune will be attending and presenting at the 20th Bioflorida Conference in St. Petersburg, Florida.

Read More